Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Qualitative and Quantitative Data for Tuberculosis Infection Prevention and Control in KwaZulu-Natal and Western Cape, South Africa, 2018-2021.
GRANT, AD; Kielmann, K;
2022
, UK Data Service (Colchester, Essex, United Kingdom) (2022).
Tuberculostearic Acid-Containing Phosphatidylinositols as Markers of Bacterial Burden in Tuberculosis.
Brandenburg, J; Heyckendorf, J; Marwitz, F; Zehethofer, N; Linnemann, L; Gisch, N; Karaköse, H; Reimann, M; KRANZER, K; Kalsdorf, B; Sanchez-Carballo, P; Weinkauf, M; Scholz, V; Malm, S; Homolka, S; Gaede, KI; Herzmann, C; Schaible, UE; Hölscher, C; Reiling, N; Schwudke, D;
2022
ACS infectious diseases, (2022).8 7 10.1021/acsinfecdis.2c00075.
A next generation BCG vaccine moves forward.
DOCKRELL, HM;
2022
The Lancet. Infectious diseases, (2022).22 10 10.1016/s1473-3099(22)00287-0.
The effect of helminth infection on vaccine responses in humans and animal models: A systematic review and meta-analysis.
NATUKUNDA, A; ZIRIMENYA, L; Nassuuna, J; NKURUNUNGI, G; COSE, S; ELLIOTT, AM; WEBB, EL;
2022
Parasite Immunology, (2022).44 9 10.1111/pim.12939.
Alternative cost-effective media to facilitate MODS culture for diagnostics of tuberculosis.
Sheen, P; Rodriguez, J; Alcántara, R; Vargas, J; Grandjean, L; MOORE, DA J; Gilman, RH; Zimic, M;
2022
TUBERCULOSIS, (2022).135, 10.1016/j.tube.2022.102225.
Estimating the contribution of subclinical tuberculosis disease to transmission – an individual patient data analysis from prevalence surveys.
EMERY, J; Dodd, P; Banu, S; Frascella, B; Garden, F; HORTON, K; Hossain, S; Law, I; Van Leth, F; Marks, G; Nguyen, HB; Nguyen, HV; Onozaki, I; Quelapio, MI; RICHARDS, A; SHAIKH, N; Tiemersma, E; WHITE, R; Zaman, K; Cobelens, F; Houben, RM G J;
2022
medRxiv (2022). 10.1101/2022.06.09.22276188.
Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion.
Simmons, JD; Dill-McFarland, KA; Stein, CM; Van, PT; Chihota, V; Ntshiqa, T; Maenetje, P; Peterson, GJ; Benchek, P; Nsereko, M; Velen, K; FIELDING, KL; GRANT, AD; Gottardo, R; Mayanja-Kizza, H; Wallis, RS; Churchyard, G; Boom, WH; Hawn, TR;
2022
mSphere, (2022).7 3 10.1128/msphere.00159-22.
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuber...
Berry, C; Du Cros, P; FIELDING, K; Gajewski, S; Kazounis, E; McHugh, TD; Merle, C; Motta, I; MOORE, DA J; NYANG'WA, B-T;
2022
Trials, (2022).23 1 10.1186/s13063-022-06331-8.
Risk Factors for Hospitalization or Death Among Adults With Advanced HIV at Enrollment for Care in South Africa: A Secondary Analysis of the TB Fast Track Trial.
CALDERWOOD, CJ; Tlali, M; Karat, AS; Hoffmann, CJ; Charalambous, S; Johnson, S; GRANT, AD; FIELDING, KL;
2022
Open Forum Infectious Diseases, (2022).9 7 10.1093/ofid/ofac265.
End-point definition and trial design to advance tuberculosis vaccine development.
Garcia-Basteiro, AL; WHITE, RG; Tait, D; Schmidt, AC; Rangaka, MX; Quaife, M; Nemes, E; Mogg, R; Hill, PC; Harris, RC; Hanekom, WA; Frick, M; Fiore-Gartland, A; Evans, T; Dagnew, AF; Churchyard, G; Cobelens, F; Behr, MA; Hatherill, M;
2022
European respiratory review, (2022).31 164 10.1183/16000617.0044-2022.